05B4 Hurwitz, Mark - Thomas Jefferson University - Thomas Jefferson University
mdh006

Mark Hurwitz, MD, FACRO

Contact Dr. Hurwitz

111 South 11th Street
Bodine Cancer Center,
Suite G-301
Philadelphia, PA 19107

(215) 955-6644
(215) 955-0412 fax

Most Recent Peer-reviewed Publications

  1. Optimization of chest wall hyperthermia treatment using a virtual human chest model
  2. Is robotic arm stereotactic body radiation therapy 'virtual high-dose rate brachytherapy' effective for prostate cancer? An analysis of comparative effectiveness using published data
  3. What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation
  4. Focused ultrasound for treatment of bone tumours
  5. International consensus on use of focused ultrasound for painful bone metastases: Current status and future directions
  6. What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation
  7. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: Phase III trial results
  8. High dose rate brachytherapy boost for prostate cancer: A systematic review
  9. A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer
  10. Components of a hyperthermia clinic: Recommendations for staffing, equipment, and treatment monitoring
  11. The quality frontier
  12. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial results.
  13. Hyperthermia, radiation and chemotherapy: The role of heat in multidisciplinary cancer care
  14. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma
  15. Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer?
  16. Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer
  17. Evolution of advanced technologies in prostate cancer radiotherapy
  18. Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: Implications for focal therapy
  19. Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiation
  20. Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: Long-term results of CALGB 99809
0